Amgen and India’s Jubilant In Drug Discovery Partnership
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Jubilant Biosys, a subsidiary of Indian contract research and manufacturing services provider Jubilant Organosys, has entered into a drug discovery partnership with Amgen to develop a portfolio of new drugs across various therapeutic areas
You may also be interested in...
India’s Jubilant Shakes Hands With Endo Pharma For Drug Discovery,
Deal marks the sixth discovery and lead optimization deal for the firm in 18 months.
India’s Jubilant Shakes Hands With Endo Pharma For Drug Discovery,
Deal marks the sixth discovery and lead optimization deal for the firm in 18 months.
India’s Jubilant Shakes Hands With Endo Pharma For Drug Discovery, Strikes Its Sixth Partnership In 18 Months
MUMBAI - Jubilant Biosys - a subsidiary of Indian pharmaceutical company Jubilant Organosys - is riding high on the collaborative research theme between Indian and multinational drug companies